Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23188430)

1.

Current data in clinicopathological characteristics of primary hepatic tumors.

Turdean S, Gurzu S, Turcu M, Voidazan S, Sin A.

Rom J Morphol Embryol. 2012;53(3 Suppl):719-24.

2.

Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Yu XH, Xu LB, Zeng H, Zhang R, Wang J, Liu C.

Hepatobiliary Pancreat Dis Int. 2011 Dec;10(6):620-5.

3.

Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.

Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T, Makuuchi M.

Jpn J Clin Oncol. 2003 Jun;33(6):283-7.

4.

Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

Fowler KJ, Sheybani A, Parker RA 3rd, Doherty S, M Brunt E, Chapman WC, Menias CO.

AJR Am J Roentgenol. 2013 Aug;201(2):332-9. doi: 10.2214/AJR.12.9488.

PMID:
23883213
5.

Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.

Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D.

Cancer. 2002 Apr 1;94(7):2040-6.

6.

Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX.

Hepatobiliary Pancreat Dis Int. 2007 Apr;6(2):161-5.

7.

Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.

Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N.

J Hepatobiliary Pancreat Surg. 2006;13(6):537-42. Epub 2006 Nov 30.

PMID:
17139428
8.

Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW.

Surg Today. 2006;36(10):892-7.

PMID:
16998683
9.

Hepatic resection for combined hepatocellular and cholangiocarcinoma.

Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, Wong J.

Arch Surg. 2003 Jan;138(1):86-90.

PMID:
12511158
10.

Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea.

Park H, Choi KH, Choi SB, Choi JW, Kim do Y, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY.

Yonsei Med J. 2011 Sep;52(5):753-60. doi: 10.3349/ymj.2011.52.5.753.

11.

Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.

Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM.

Ann Surg Oncol. 2008 Jul;15(7):1880-90. doi: 10.1245/s10434-008-9933-y. Epub 2008 Apr 29.

PMID:
18443881
12.

A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.

Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umeshita K, Monden M.

Hepatogastroenterology. 2007 Mar;54(74):508-13.

PMID:
17523309
13.

[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].

Tischoff I, Tannapfel A.

Zentralbl Chir. 2007 Aug;132(4):300-5. Review. German.

PMID:
17724632
14.

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.

Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.

Liver Transpl. 2007 Jun;13(6):807-13.

15.

Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.

Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J.

Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.

PMID:
22451237
16.

Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.

Lee CH, Hsieh SY, Chang CJ, Lin YJ.

J Gastroenterol Hepatol. 2013 Jan;28(1):122-7. doi: 10.1111/j.1440-1746.2012.07289.x.

PMID:
23034166
17.

Hepatobiliary malignancies. Primary hepatic malignant neoplasms.

Molmenti EP, Marsh JW, Dvorchik I, Oliver JH 3rd, Madariaga J, Iwatsuki S.

Surg Clin North Am. 1999 Feb;79(1):43-57, viii. Review.

PMID:
10073181
18.

Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2009 Mar;16(3):623-9. doi: 10.1245/s10434-008-0278-3. Epub 2009 Jan 6.

PMID:
19130133
19.

The use of immunohistochemistry in liver tumors.

Chan ES, Yeh MM.

Clin Liver Dis. 2010 Nov;14(4):687-703. doi: 10.1016/j.cld.2010.10.001. Review.

PMID:
21055690
20.

[A case of double liver cancer: hepatocellular carcinoma and combined hepatocellular and mucinous cholangiocarcinoma].

Yamashita N, Nishiura S, Tanimoto H, Yamamoto H, Nomura H.

Nihon Shokakibyo Gakkai Zasshi. 2013 Sep;110(9):1663-72. Japanese.

PMID:
24005108
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk